Magnetic resonance imaging (MRI) has high sensitivity for detection of breast cancer but low specificity. Qualitative and quantitative measurements of choline containing (tCho) compounds by MR spectroscopy have shown promise in diagnosis as well as in non-invasive therapeutic assessment of breast cancer. Diffusion weighted imaging (DWI) allows mapping of apparent diffusion coefficient (ADC) of tissues. The lower ADC value has been reported in malignant compared to benign disease. Use of these techniques in combination has been documented to increase the specificity of MRI. This talk highlights the role of MRS and DWI in breast cancer management.